Skip to main content
Verified by IngredientMD/Gaia Herbs/Ashwagandha Root
VERIFIED BYingredientMD

Ashwagandha Root.

Strong for its nicheGaia Herbs, verified Oct 2026Formula verified. Independently reviewed.Independent review. Not commissioned by Gaia Herbs.

Ashwagandha is the lead active here, studied most for everyday stress. In the 350 mg Proprietary Extract Blend, listed first. 21 human studies on Ashwagandha back this formula, each one cited. Each serving carries 350 mg of Ashwagandha, inside the range the published research used. Who it fits: for everyone, adults.

Clinically dosedFull label disclosure
3Active ingredients24Human studies
Ashwagandha RootVerified by IngredientMD
Gaia HerbsIngredientMD
The verdict
Strong for its niche
For everyone, adults.
How we verify

The brand submits the formula. We read the supplement facts panel and weigh dose, form and synergy against the clinical evidence. Labs test. IngredientMD verifies. The fee pays for review time, never for the outcome.

The formula
Proprietary Extract Blend: A 350 mg blend of one ingredient, listed by weight.Supporting role
Ashwagandha: Everyday stress. In the 350 mg Proprietary Extract Blend, listed first.Key driver
Withanolides: Everyday stressWell studied

How we read this product

Source: Supplement facts
Supplement Facts panel for Ashwagandha Root
  1. 01
    We read the label.

    The panel on the left is the one we evaluated, line by line.

  2. 02
    Every active, separately.

    All 3 actives checked against the clinical evidence: dose, form, and what the research actually shows.

  3. 03
    Then the formula as a whole.

    Doses, ratios, and how the ingredients work together. That assessment is the verdict above: "Strong for its niche".

  4. 04
    Earned, not bought.

    The verdict is public and identical whether or not a brand pays. A formula that does not clear the bar gets nothing.

Read by the engine against 2.1 million data points from clinical trials, PubMed and more than a hundred vetted sources. No individual reviewer is named or implied.

The receipts

24
Human studies
350 mg per serving sits inside the studied 300 mg-600 mg range
Ashwagandha, Chandrasekhar 2012 + Lopresti 2019 meta-analysis

Cross-checked against 14 documented interactions for these actives.

Read the evidenceAshwagandha, the evidence →Withanolides, the evidence →

Inside the formula

Proprietary Extract Blend
A 350 mg blend of one ingredient, listed by weight.
Supporting role
Ashwagandha
21 studies
Everyday stress. In the 350 mg Proprietary Extract Blend, listed first.
Studied 300 mg to 1.2 g a day
Key driver
Withanolides
Everyday stress
Well studied
In context

The gap this formula speaks to.

Public health figures the engine matched to this formula's ingredients. Reported by their source, cited and dated, never written by the brand.

The people it speaks toFieldwork 2024

12% of US adults

regularly reported feelings of worry, nervousness, and anxiety in 2024, in the National Health Interview Survey.

CDC National Center for Health Statistics, 2024
The people it speaks toFieldwork 2024

39% of adults worldwide

said they worried a lot the previous day, in the Gallup World Poll fielded in 2024 across 144 countries and territories.

Gallup, 2024
The people it speaks toFieldwork 2024

37% of adults worldwide

said they felt stressed the previous day, in the Gallup World Poll fielded in 2024 across 144 countries and territories.

Gallup, 2024
This formulaNHANES 2017-2018, published 2021

57.6%

During 2017 to 2018, 57.6% of US adults aged 20 and over reported using a dietary supplement in the past 30 days.

CDC National Center for Health Statistics
Daily usePublished 2024

59 to 66 days

was the median time it took adults to make a new daily health habit automatic across the studies a 2024 review pooled, with individuals ranging from 4 to 335 days.

Systematic review and meta-analysis, 2024
12 more
Ashwagandha

Meta-analysis, 2025

In a pooled analysis of supplement trials, ashwagandha was among the interventions linked with better self-reported sleep quality.

Nutrients
Withanolides

Randomised trial, 2026

A placebo-controlled trial of low-dose ashwagandha supplementation reported exercise endurance measures over the supplementation period.

Phytotherapy Research
Withanolides

Systematic review, 2026

Reviewing human trials, withanolide-bearing Withania somnifera extracts were associated with modest gains in cognitive test scores and physical function measures.

Frontiers in pharmacology
Withanolides

Systematic review, 2023

Across randomised trials in adults under stress, withanolide-standardised Withania somnifera extracts lowered circulating cortisol compared with placebo.

Nutrients
Ashwagandha

Meta-analysis, 2024

Pooling nine randomized trials in 558 adults, ashwagandha lowered perceived stress scores by about 4.7 points and serum cortisol by about 2.6 micrograms per deciliter compared with placebo.

Explore
Ashwagandha

Meta-analysis, 2021

Across five randomized trials in 400 adults, ashwagandha extract improved overall sleep with a small pooled effect (standardized mean difference -0.59), most noticeable at doses of 600 mg or more per day taken for at least eight weeks.

PLoS One
Ashwagandha

Meta-analysis, 2020

Pooling four randomized trials in 142 athletes and healthy adults, ashwagandha raised maximal oxygen uptake (VO2max) by about 3.0 mL/kg/min compared with placebo.

Nutrients
Ashwagandha

Meta-analysis, 2026

Across randomised trials, ashwagandha supplementation was associated with small gains in exercise performance measures such as strength and oxygen uptake.

Nutrients
Withanolides

Narrative review, 2026

A narrative review of ashwagandha in physical performance contexts, mapping the reported strength, recovery and endurance measures and the limits of the trial base.

Nutrition and Metabolism
Withanolides

Randomised trial, 2025

Supplementation with a standardised ashwagandha formulation was reported to improve self-rated stress, mood and sleep quality scores. These are questionnaire ratings rather than clinical endpoints.

Advances in Therapy
Withanolides

Randomised trial, 2025

A single-dose crossover trial found higher blood levels of active compounds from a 1.5 percent standardised ashwagandha formula than from a comparison product. This measures absorption, not a functional benefit.

Advances in Therapy

Population figures from public health data. Context for the category, not a statement about any individual and not a claim about this product.

What this formula earned

Every one of these is a fact the engine could ground.

Each line below was derived from this formula's own record at the time of verification. Nothing here was written by the brand, and nothing can be added that the evidence does not carry.

  • Studied in people21 human studies on Ashwagandha back this formula, each one cited.
  • A mechanism that is settledHow Ashwagandha and Withanolides work is settled pharmacology.
  • Recent work on the recordThe most recent study on this record was published in 2026.
  • Serving amount inside the studied rangeEach serving carries 350 mg of Ashwagandha, inside the range the published research used.
  • A stated daily maintenance amountAshwagandha is here at a daily maintenance amount, which is what a daily supplement is for.
  • Why this formatIt is a capsule, so the amount per serving is fixed and travels without measuring.
  • The exact form, describedThe label names its forms exactly: Milled ashwagandha root powder, Whole-plant Withania somnifera extract, root plus aerial parts. The record says what each one is and what it suits.
  • A declared blend totalProprietary Extract Blend declares its total, 350 mg per serving, with 1 ingredient listed by weight.
  • Where it comes from and how it is madeAshwagandha is made by botanical.
  • Positions this formula already qualifies forThis formula already qualifies for positions beyond the one it is sold into, on the evidence it carries.
  • A position nobody is holding yetSome of those positions are ones almost nobody is selling to yet.
What the trials show

What the trials show about timing.

Time-to-effect windows the engine read from the trial record. Each is a window a named study measured, cited and dated, never written by the brand.

  • Ashwagandhaabout eight to nine weeks of daily useBuilds with daily use

    In a 60 day randomised, double-blind, placebo-controlled trial, 60 stressed healthy adults took 240 mg of a standardised ashwagandha extract (Shoden) once daily or placebo. The ashwagandha arm showed a larger fall in Hamilton Anxiety Rating Scale scores (p = .040) and in morning cortisol (p < .001) than placebo, with the DASS-21 change near-significant (p = .096). A separate 8 week randomised, double-blind, placebo-controlled dose-ranging trial enrolled 131 adults with self-reported high stress and analysed 98, measuring reduced Perceived Stress Scale scores at 125, 250 and 500 mg per day of an aqueous root and leaf extract. Two trials on two different extracts, both landing in the same eight to nine week band.

    Promising

Windows measured in the cited trials. Context for how the active behaves over time, not a statement about any individual and not a claim about this product.

General timing

How each ingredient usually behaves over time.

Two ingredients, from each one's own page.

How each ingredient usually behaves over time, from its own page on IngredientMD. General timing for the ingredient, not a measurement of this product.

Format

Capsule

It is a capsule, so the amount per serving is fixed and travels without measuring.

Best forMost standard doses, and anywhere a short, clean label is the point.
From the same shelf

Studied alongside this brand's other formulas

Where two of this brand's products carry actives the literature has read together, the pairing and its basis are below. The evidence word is the corpus row's own confidence, never a score.

Ashwagandha Root + Rhodiola RoseaPromising

Rhodiola and withanolide-bearing ashwagandha are both described in adaptogen reviews as acting on stress-response signalling, including the hypothalamic-pituitary-adrenal axis. Rhodiola is usually taken in the morning and withanolides at either end of the day. The combination is a traditional and commercial pairing. The shared axis is the rationale, not a measured additive effect.

PMID 41901106

Holy Basil Leaf + Ashwagandha RootPromising

Holy basil and ashwagandha are both examined for effects on hypothalamic-pituitary-adrenal signalling rather than on a single receptor. Because their phytochemistry differs (eugenol and ursolic acid versus withanolides), a combined preparation is not simply a larger dose of one plant. Human data for the pairing come from mixed formulas, so the effect of each component cannot be separated out. Anyone already using a sedating product should account for the combined load.

PMID 33650944

Questions shoppers ask

Is Ashwagandha Root independently verified?
Yes. IngredientMD reviewed this formula independently and verified it in Oct 2026. The verdict is earned, not bought: brands can't edit or purchase it.
What's in Ashwagandha Root?
Ashwagandha Root is built on Proprietary Extract Blend, Ashwagandha, Withanolides. Each ingredient links to its own evidence page on IngredientMD.
Were ingredient interactions checked?
Yes. The combination was screened against 14 documented interactions for these actives in IngredientMD's interaction database.
Who is IngredientMD?
IngredientMD is an independent supplement-science platform. We analyze ingredients and formulas against clinical research, and we verify products only when they clear our bar. Labs run the tests. We review the results.
Sell a formula this good?

Put an earned verification on your own product page.

Get verified

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This record is not medical advice. Always consult your healthcare provider before starting any supplement regimen.

Independent review by IngredientMD, not commissioned by Gaia HerbsWork at Gaia Herbs? This verification is yours to claim →